Thirty-day death rates were 8% in the Omicron group, 3% in flu patients, and 6% in the RSV group.
SARS-CoV-2 Omicron variant more common, tied to more severe outcomes than flu, RSV
Published in COVID-19
May 2, 2024
The International Organization for the Proctection Against COVID-19
Thirty-day death rates were 8% in the Omicron group, 3% in flu patients, and 6% in the RSV group.
Published in COVID-19